Drugs & Therapy Perspectives

, Volume 18, Issue 3, pp 18–22 | Cite as

Using antimicrobials to treat complicated urinary tract infection

Disease Management
  • 19 Downloads

Keywords

Urinary Tract Infection Malignant Pleural Mesothelioma Gatifloxacin Neurogenic Bladder Asymptomatic Bacteriuria 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nicolle LE. A practical guide to antimicrobial management of complicated urinary tract infection. Drugs Aging 2001; 18(4): 243–54PubMedCrossRefGoogle Scholar
  2. 2.
    Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis North Am 1997; 11: 647–67CrossRefGoogle Scholar
  3. 3.
    Nicolle LE, Louie TJ, Dubois J, et al. Treatment of complicated urinary tract infections with lomefloxacin compared with trimethoprim/sulfamethazole. Antimicrob Agents Chemother 1994; 38: 1368–73PubMedCrossRefGoogle Scholar
  4. 4.
    Cox CE, Holloway WJ, Geckler RW. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Clin Infect Dis 1995; 21: 86–92PubMedCrossRefGoogle Scholar
  5. 5.
    Cardenas DD, Hooton TM. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehab 1995; 76: 272–80CrossRefGoogle Scholar
  6. 6.
    Rodgers K, Nicolle LE, McIntyre M, et al. Pyuria in institutionalized elderly patients. Can J Infect Dis 1991; 2: 142–6PubMedGoogle Scholar
  7. 7.
    Rubin RH, Shapiro ED, Andriole VT, et al. Evaluation of new anti-infective drugs for treatment of urinary tract infection. Clin Infect Dis 1992; 15 Suppl 1: S216–27PubMedCrossRefGoogle Scholar
  8. 8.
    Patterson TF, Andriole VT. Detection, significance and therapy of bacteriuria in pregnancy: update in the managed health care era. Infect Dis Clinics North Am 1997; 11: 593–603CrossRefGoogle Scholar
  9. 9.
    Gleckman R, Crowley, M, Natsias GA. Recurrent urinary tract infections in men: an assessment of contemporary treatment. Am J Med Sci 1980; 279: 31–6PubMedCrossRefGoogle Scholar
  10. 10.
    Sheehan GJ, Harding GKM, Haase DA, et al. Double-blind randomized comparison of 24 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicate d urinary tract infection. Antimicrob Agents Chemother 1988; 32: 1292–3PubMedCrossRefGoogle Scholar
  11. 11.
    Tambyah PA, Maki DG. Catheter associated urinary tract infection is rarely symptomatic. Arch Intern Med 2000; 160: 678–82PubMedCrossRefGoogle Scholar
  12. 12.
    Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement prior to antimicrobial therapy for symptomatic urinary infection. J Urol 2000; 164: 1254–8PubMedCrossRefGoogle Scholar
  13. 13.
    Zhanel G, Harding GKM, Nicolle LE. Asymptomatic bacteriuria in diabetics. Rev Infect Dis 1991; 13: 150–4PubMedCrossRefGoogle Scholar
  14. 14.
    Nicolle LE. Asymptomatic bacteriuria in diabetic women. Diabetes Care 2000; 23: 722–3PubMedCrossRefGoogle Scholar
  15. 15.
    Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria: a randomized double-blind study of treatment with fluconazole and placebo. The National Institute for Allergy and Infectious Diseases (NIAID) Mycose Study Group. Clin Dis 2000; 30: 19–24CrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Personalised recommendations